Synovus Financial Corp Buys 2,461 Shares of Walgreens Boots Alliance Inc (WBA)

Synovus Financial Corp boosted its stake in shares of Walgreens Boots Alliance Inc (NASDAQ:WBA) by 19.9% in the 3rd quarter, according to its most recent Form 13F filing with the SEC. The fund owned 14,815 shares of the pharmacy operator’s stock after purchasing an additional 2,461 shares during the period. Synovus Financial Corp’s holdings in Walgreens Boots Alliance were worth $1,081,000 as of its most recent filing with the SEC.

A number of other hedge funds and other institutional investors also recently modified their holdings of WBA. Sei Investments Co. lifted its position in shares of Walgreens Boots Alliance by 100.9% in the second quarter. Sei Investments Co. now owns 349,451 shares of the pharmacy operator’s stock valued at $20,970,000 after buying an additional 175,551 shares during the last quarter. California Public Employees Retirement System lifted its position in shares of Walgreens Boots Alliance by 7.7% in the second quarter. California Public Employees Retirement System now owns 2,303,917 shares of the pharmacy operator’s stock valued at $138,270,000 after buying an additional 165,048 shares during the last quarter. Bridgewater Associates LP lifted its position in shares of Walgreens Boots Alliance by 109.1% in the second quarter. Bridgewater Associates LP now owns 657,649 shares of the pharmacy operator’s stock valued at $39,469,000 after buying an additional 343,062 shares during the last quarter. Schaller Investment Group Inc. bought a new position in shares of Walgreens Boots Alliance during the second quarter worth approximately $9,152,000. Finally, We Are One Seven LLC bought a new position in shares of Walgreens Boots Alliance during the third quarter worth approximately $1,295,000. 64.57% of the stock is owned by hedge funds and other institutional investors.

A number of equities analysts have recently weighed in on the company. Barclays increased their target price on Walgreens Boots Alliance from $77.00 to $80.00 and gave the stock an “equal weight” rating in a research note on Friday, October 12th. BidaskClub upgraded Walgreens Boots Alliance from a “hold” rating to a “buy” rating in a research note on Wednesday, September 12th. Citigroup increased their target price on Walgreens Boots Alliance from $69.00 to $76.00 and gave the stock a “neutral” rating in a research note on Friday, October 12th. Zacks Investment Research upgraded Walgreens Boots Alliance from a “hold” rating to a “buy” rating and set a $81.00 target price on the stock in a research note on Tuesday, September 25th. Finally, Robert W. Baird increased their target price on Walgreens Boots Alliance from $64.00 to $69.00 and gave the stock a “neutral” rating in a research note on Tuesday, September 11th. One analyst has rated the stock with a sell rating, eleven have issued a hold rating, seven have issued a buy rating and two have issued a strong buy rating to the company. The company has an average rating of “Hold” and a consensus price target of $78.22.

In other Walgreens Boots Alliance news, Director William C. Foote sold 2,736 shares of the firm’s stock in a transaction on Thursday, November 1st. The stock was sold at an average price of $79.48, for a total value of $217,457.28. Following the sale, the director now owns 8,207 shares of the company’s stock, valued at approximately $652,292.36. The sale was disclosed in a document filed with the SEC, which is available at the SEC website. Also, SVP Kimberly R. Scardino sold 11,970 shares of the firm’s stock in a transaction on Thursday, November 1st. The shares were sold at an average price of $79.79, for a total value of $955,086.30. The disclosure for this sale can be found here. In the last 90 days, insiders have sold 66,706 shares of company stock worth $5,268,584. Corporate insiders own 14.80% of the company’s stock.

Walgreens Boots Alliance stock opened at $81.00 on Wednesday. Walgreens Boots Alliance Inc has a one year low of $59.07 and a one year high of $80.68. The company has a debt-to-equity ratio of 0.47, a quick ratio of 0.38 and a current ratio of 0.82. The firm has a market cap of $75.27 billion, a price-to-earnings ratio of 13.39, a P/E/G ratio of 1.23 and a beta of 0.74.

Walgreens Boots Alliance (NASDAQ:WBA) last posted its quarterly earnings data on Thursday, October 11th. The pharmacy operator reported $1.48 EPS for the quarter, topping the Zacks’ consensus estimate of $1.45 by $0.03. Walgreens Boots Alliance had a return on equity of 21.75% and a net margin of 3.82%. The firm had revenue of $33.44 billion for the quarter, compared to analyst estimates of $33.64 billion. Equities research analysts expect that Walgreens Boots Alliance Inc will post 6.54 earnings per share for the current fiscal year.

The business also recently disclosed a quarterly dividend, which will be paid on Wednesday, December 12th. Shareholders of record on Monday, November 12th will be paid a dividend of $0.44 per share. The ex-dividend date of this dividend is Thursday, November 8th. This represents a $1.76 dividend on an annualized basis and a yield of 2.17%. Walgreens Boots Alliance’s dividend payout ratio (DPR) is presently 29.24%.

WARNING: “Synovus Financial Corp Buys 2,461 Shares of Walgreens Boots Alliance Inc (WBA)” was reported by WKRB News and is the property of of WKRB News. If you are accessing this piece on another site, it was stolen and republished in violation of United States and international copyright law. The legal version of this piece can be accessed at https://www.wkrb13.com/2018/11/07/synovus-financial-corp-buys-2461-shares-of-walgreens-boots-alliance-inc-wba.html.

Walgreens Boots Alliance Company Profile

Walgreens Boots Alliance, Inc operates as a pharmacy-led health and wellbeing company. It operates through three segments: Retail Pharmacy USA, Retail Pharmacy International, and Pharmaceutical Wholesale. The Retail Pharmacy USA segment sells prescription drugs and an assortment of general merchandise, including non-prescription drugs, beauty products, photo finishing, seasonal merchandise, greeting cards, and convenience foods through its retail drugstores and convenient care clinics.

Featured Story: NASDAQ Stock Market Explained

Want to see what other hedge funds are holding WBA? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Walgreens Boots Alliance Inc (NASDAQ:WBA).

Institutional Ownership by Quarter for Walgreens Boots Alliance (NASDAQ:WBA)

Receive News & Ratings for Walgreens Boots Alliance Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Walgreens Boots Alliance and related companies with MarketBeat.com's FREE daily email newsletter.

Leave a Reply